HIGHLIGHTS   |  January 9, 2020   Proton Chemoradiotherapy May Be Associated with Reduced Adverse Events These results could present an opportunity to broaden inclusion criteria on clinical trials and intensify chemoradiotherapy treatments. Read more ADVERTISEMENT Proven portfolio of tests + services, that’s our Foundation. Our portfolio of genomic tests & services is designed for cancer patients at any line of therapy, with proven utility for clinical decision making. Rx only; advanced cancer; doesn’t guarantee treatment match. Learn more     Phase III JAVELIN Bladder 100 Meets Primary Endpoint of Overall Survival The study found that patients who were randomized to receive avelumab and best supportive care lived significantly longer than those who only received best supportive care. Read more   In Case You Missed It   Single Dose Radiotherapy Effective for Patients with Malignant Spinal Cord Compression A study published in JAMA suggested that a single dose of radiotherapy is as effective as 5 doses for patients with malignant metastatic solid tumors and spinal canal compression. Read more